Interestingly, Oct-4 is also re-expressed in germ cell tumors [8], breast cancer [9], bladder cancer [10], prostate cancer and hepatomas [11,12], but very little is known about its potential function in malignant disease [13]. This evidence concerns the gene POU5F1 and prostate carcinoma.